VitaStir Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: a low first-month price on compounded semaglutide, with the full dose ladder published
VitaStir scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $125 a month; its compounded tirzepatide, at $145, is 46% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
VitaStir is a Michigan vitamin-injection clinic that also sells compounded semaglutide and tirzepatide as monthly home kits after a physician review. The kit price rises with the dose: semaglutide runs $125 to $395 a month and tirzepatide $145 to $599. Kits are non-refundable once approved, and subscriptions bill every 25 days.
Is VitaStir legit?
Yes. VitaStir is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 8.1/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a VitaStir promo or coupon code?
VitaStir publishes the code WELCOME10 (New customer discount: 10% off with code WELCOME10 (site store-notice banner)). You enter it at checkout on VitaStir's own site. Other codes for VitaStir circulate on coupon sites, and we cannot vouch for those.
See how VitaStir compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to VitaStir
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
VitaStir at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $125/mo
- Pricing model
- Rises with the dose: higher doses cost more
- What's included
- Medication · Consult
- FDA status
- No FDA warning letters found
How VitaStir scores
Six columns, each one computed from something VitaStir has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
9.5/10$145/month is 46% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on VitaStir
Last checked October 2026- Checked the listed price across 11 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for VitaStir
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with VitaStir involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1VitaStir shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask VitaStir which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $125, tirzepatide $145. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that VitaStir serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling VitaStir
Taken from the terms VitaStir publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None; subscriptions bill every 25 days
- Refund policy
- Refunded if not approved by the physician; otherwise all products are non-refundable
- Early-termination fee
- None
Medications VitaStir lists
VitaStir lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides VitaStir offers
VitaStir sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Sale price; shown struck from $599. Kit price at the starting dose.
Sale price; shown struck from $399. Kit price at the starting dose.
Check the price yourself before you pay
Every figure here comes from VitaStir's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $125 a month, 37% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $145 a month, 46% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to VitaStir
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What VitaStir charges
The standing price at VitaStir is $125/month.
- Compounded semaglutide (0.25 mg): $125/month
- Compounded semaglutide (0.5 mg): $245/month
- Compounded semaglutide (1.0 mg): $295/month
- Compounded semaglutide (1.7 mg): $345/month
- Compounded semaglutide (2.5 mg): $395/month
- Compounded tirzepatide (2.5 mg): $145/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so VitaStir's $145 is genuinely below the middle, not just advertised that way. Before you pay, compare VitaStir's cancellation terms with other sellers' cancellation and refund policies.
bmiMD, at about $129/month, is the closest like-for-like alternative we review.
What VitaStir dispenses
VitaStir prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. Some of VitaStir's preparations are mixed with B12; why compounders add it separates what is established from what is only claimed.
Safety and disclosure
VitaStir tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to VitaStir. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If VitaStir will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
VitaStir also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether VitaStir bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
VitaStir competes on price without an obvious sacrifice elsewhere: $145/month for compounded tirzepatide, no FDA warning letters.
The Bottom Line
VitaStir scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $125 a month; its compounded tirzepatide, at $145, is 46% below the $269 median among the sellers we compare.
Before you pay VitaStir
Starting at $125 a month. Check today's price, then start the intake.
Where VitaStir is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to VitaStir sets more sellers in the same category beside VitaStir on price, states and what the price includes.
Frequently Asked Questions
How to check VitaStir yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this VitaStir review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See VitaStir's current pricing
Plans start at $125 a month. Whether you qualify is a clinician's decision, made after your intake.